Monarch Partners Asset Management LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 187 filers reported holding IMMUNOGEN INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
Monarch Partners Asset Management LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2022$3,226,000
+114.6%
674,845
+195.8%
0.97%
+348.6%
Q2 2021$1,503,000
+99.9%
228,125
+145.9%
0.22%
+91.2%
Q1 2021$752,000
+9.8%
92,780
-12.6%
0.11%
-5.8%
Q4 2020$685,000
+61.6%
106,165
-9.8%
0.12%
+26.3%
Q3 2020$424,000
+15.5%
117,645
+47.6%
0.10%
+5.6%
Q2 2020$367,00079,7250.09%
Other shareholders
IMMUNOGEN INC shareholders Q3 2020
NameSharesValueWeighting ↓
Redmile Group, LLC 10,906,962$69,914,0003.04%
Fernwood Investment Management, LLC 224,500$1,439,0000.77%
Telemetry Investments, L.L.C. 272,000$1,744,0000.66%
Schonfeld Strategic Advisors LLC 865,356$5,547,0000.45%
Virtus ETF Advisers LLC 53,977$346,0000.43%
Endurant Capital Management LP 210,800$1,351,0000.41%
SPHERA FUNDS MANAGEMENT LTD. 500,000$3,205,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 113,216$726,0000.37%
Orbimed Advisors 2,834,126$18,167,0000.23%
PINNACLE ASSOCIATES LTD 1,322,231$8,476,0000.16%
View complete list of IMMUNOGEN INC shareholders